Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
80.38
+0.91 (1.15%)
Dec 5, 2025, 4:00 PM EST - Market closed
Monopar Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 5.74 | 3.16 | 3.23 | 2.95 | 2.63 | 2.44 | |
| Research & Development | 15.89 | 13.01 | 5.6 | 7.59 | 6.49 | 4.07 | |
| Operating Expenses | 21.62 | 16.16 | 8.83 | 10.54 | 9.13 | 6.51 | |
| Operating Income | -21.62 | -16.16 | -8.83 | -10.54 | -9.13 | -6.51 | |
| Interest & Investment Income | 2.18 | 0.4 | 0.43 | 0.02 | 0.02 | 0.08 | |
| Other Non Operating Income (Expenses) | 0 | 0.17 | - | - | - | - | |
| EBT Excluding Unusual Items | -19.44 | -15.59 | -8.4 | -10.52 | -9.1 | -6.43 | |
| Other Unusual Items | - | - | - | - | - | 0.12 | |
| Pretax Income | -19.44 | -15.59 | -8.4 | -10.52 | -9.1 | -6.3 | |
| Net Income | -19.44 | -15.59 | -8.4 | -10.52 | -9.1 | -6.3 | |
| Net Income to Common | -19.44 | -15.59 | -8.4 | -10.52 | -9.1 | -6.3 | |
| Shares Outstanding (Basic) | 7 | 4 | 3 | 3 | 2 | 2 | |
| Shares Outstanding (Diluted) | 7 | 4 | 3 | 3 | 2 | 2 | |
| Shares Change (YoY) | 97.28% | 37.09% | 8.70% | 1.97% | 13.82% | 17.56% | |
| EPS (Basic) | -2.99 | -4.11 | -3.04 | -4.13 | -3.65 | -2.88 | |
| EPS (Diluted) | -2.99 | -4.11 | -3.04 | -4.13 | -3.65 | -2.88 | |
| EBIT | -21.62 | -16.16 | -8.83 | -10.54 | -9.13 | -6.51 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.